Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...
Winter skin woes: Top nutrients to combat dryness and irritation
As winter weather persists across much of the country, many people are experiencing flare-ups of skin conditions.
Business Wire2d
Amneal Launches Mesalamine and Receives U.S. FDA Approval for Lenalidomide
“Mesalamine is a difficult to make product with a limited number of suppliers, and this approval highlights the strength of our R&D capabilities. Additionally, the approval of lenalidomide represents ...
Amneal launches Mesalamine; receives U.S. FDA Lenalidomide approval
Amneal Pharmaceuticals (AMRX) announced the launch of mesalamine 800 mg delayed-release tablets, an aminosalicylate indicated for the treatment ...
Canada3d
February is Black History Month
Each February, people across Canada participate in Black History Month events and celebrations that honour the legacy and contributions of Black people in Canada and their communities. The 2025 theme ...
Fortune India3d
'Facing challenges is a way of life': Nestlé India CMD Suresh Narayanan on FMCG giant's big India strategy
The Maggi controversy is behind him, but Narayanan’s tryst with challenges continues. After delivering robust volume growth ...